Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000812539 | SCV000952856 | likely benign | Landau-Kleffner syndrome | 2024-05-15 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000992091 | SCV001144087 | uncertain significance | not provided | 2020-01-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003396423 | SCV004104086 | uncertain significance | GRIN2A-related disorder | 2023-06-05 | criteria provided, single submitter | clinical testing | The GRIN2A c.916A>T variant is predicted to result in the amino acid substitution p.Met306Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-10031907-T-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |